Co-beneldopa (Benserazide/levodopa) Prescribing at THE MILLWOOD PARTNERSHIP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
489
Total Quantity
64.0K
NHS Cost
£4.5K
vs National Avg
+223.5%
THE MILLWOOD PARTNERSHIP prescribed 489 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £4,477 to the NHS. This is 223.5% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
39
Jul 2026
48
Jul 2026
39
Jul 2026
40
Jul 2026
29
Jul 2026
54
Jul 2026
49
Jul 2026
31
Jul 2026
43
Jul 2026
37
Jul 2026
39
Jul 2026
41
Prescribing Details
| Total Items | 489 |
|---|---|
| Total Quantity | 64,000 |
| Total NHS Cost | £4,477 |
| Presentations | 11 different forms |
| vs National Average | +223.5% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 489 items |
|---|---|
| National average per practice | 151 items |
| Difference | +223.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.